ORKA
Oruka Therapeutics, Inc.
79.50$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +70.7% | -34.6% | -90.8% | -15.4% | -13.0% | -20.3% | -50.6% | +431.9% | -5.6% | +145.3% | -37.8% | -49.8% | -44.8% | +25.1% | +490.8% | +8.9% | -21.6% | -12.1% | +946.0% | +23.4% | |
| – | +93.9% | -39.9% | -90.3% | -14.4% | -13.6% | -13.3% | -51.0% | +455.8% | -8.5% | +151.3% | -44.9% | -42.6% | -44.9% | +25.1% | +489.2% | +8.9% | -21.5% | -12.0% | +902.5% | -8.8% | |
| – | +59.8% | -46.9% | -75.9% | +0.3% | -9.5% | -15.4% | -50.9% | +473.8% | -8.4% | +152.7% | -80.9% | +17.6% | -24.1% | +26.6% | +486.8% | +8.7% | -20.5% | -11.8% | +64.5% | -23.8% | |
| – | +117.7% | -36.3% | -92.1% | +0.3% | -9.5% | -15.4% | -50.9% | +473.8% | -8.4% | +152.7% | -45.5% | -44.5% | -43.8% | +26.6% | +486.8% | +8.7% | -20.5% | -11.8% | +903.6% | -10.3% | |
| – | +609.1% | -93.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +123.4% | -53.7% | -69.1% | -88.0% | -29.3% | -44.4% | -60.4% | +392.8% | -7.5% | +8.1% | +61.9% | -14.2% | -62.1% | +16.8% | +322.0% | -0.7% | -63.6% | -40.4% | +1,540.7% | +20.9% | |
| – | +21.2% | -58.5% | -13.0% | -89.6% | -27.6% | -36.6% | -59.5% | +392.5% | -7.6% | +8.4% | +59.3% | -13.6% | -61.7% | +16.8% | +277.9% | 0.0% | -67.6% | -43.7% | +1,947.6% | +17.9% | |
| – | -55.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | +64.0% | +143.9% | +3.0% | -26.2% | +180.3% | +190.6% | |
| – | +42.8% | -60.7% | -70.9% | -33.7% | -27.2% | -33.0% | -75.0% | +818.5% | – | – | – | – | -63.0% | +81.7% | +324.2% | -37.0% | -70.1% | – | – | +20.0% | |
| – | +23.0% | -3.1% | -107.9% | – | -8.6% | -15.3% | -49.3% | +436.0% | -5.4% | +158.3% | -41.7% | -53.7% | -41.3% | +26.2% | +511.3% | +9.7% | -18.4% | -11.2% | +932.5% | +23.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +24.6% | +3.7% | -98.6% | +18,602.9% | +19.9% | +18.0% | +32.9% | +288.2% | +137.6% | +114.7% | +44.2% | +15.0% | +32.8% | +71.7% | +4,178.1% | +195.2% | +3.6% | +0.0% | +16.5% | +171.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.